Atlas Trials

Pharmacokinetic Equivalence and Safety Study of RPH-001 and Avastin®

Clinical trial NCT03659305 · COMPLETED

Trial details

NCT number
NCT03659305
Sponsor
R-Pharm
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2018-07-10
Primary completion
2019-01-26
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.